C&EN: "Chemours completes financial probe"
In this week's C&EN, this news (article by Alexander H. Tullo):
Chemours’s board of directors has completed an internal review of accounting irregularities that led to the ouster of CEO Mark Newman. In February, Newman was placed on leave pending the review. The probe found that $100 million in payments from Chemours to vendors due in the fourth quarter of 2023 were delayed until the first quarter of this year. Meanwhile, Chemours’s collection of $260 million in receivables due in... Читать дальше...